TABLE 2.
Antigen | Age (mo) | P value to PopB | P value to lysate |
---|---|---|---|
Western blotting | |||
ETA | 131 | <0.001c | <0.001c |
PcrV | 60 | 0.11 | <0.001c |
ExoS | 60 | 0.85 | <0.001c |
PopB | 59 | <0.001c | |
PA01 lysate | 42 | <0.001c | |
ELISA | |||
ETA | 78 | <0.001c | <0.001c |
ExoS | 60 | 0.05c | 0.003c |
ExoS/PopB | 40 | 0.33 | |
PA01 lysate | 27 | 0.33 |
Western blotting was performed after the transfer of SDS-polyacrylamide gel electrophoresis-separated proteins to PVDF membranes. The membranes were probed with longitudinal sera (diluted 1/4,000; if negative, diluted to 1/1,000) from 48 patients with CF. The sera were analyzed in at least two independent experiments, and the averages are shown. Positive seroconversion was determined relative to an internal positive control that detected an immune reaction to PopB.
ELISA was performed using 0.25 μg of purified proteins or 1 μg of PA01 cell lysate. Wells were probed with longitudinal sera (1/500 dilution) from 48 patients with CF. The sera were analyzed in at least two independent experiments with similar results; the results from one set of data are shown. Positive seroconversion was determined when the OD was 0.2 units above the negative controls (minus primary serum and minus secondary antibody).
Statistically significant (P ≤ 0.05) difference between the indicated samples.